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Figure S-2. Above are the MALDI-MS/MS spectra of 14 cardiovascular drugs, amlodipine, atorvastatin calcium, felodipine, fenofibrate, furosemide, hydrochlorothiazide, lorsartan postassium, lisinopril, metoprolol succinate, pravastatin sodium, rosuvastatin calcium, simvastatin, valsartan and verapamil.
ESI-MS and MS/MS parameters
Direct infusion positive and negative ion ESI-MS and MS/MS experiments were conducted using a Thermo Q Exactive mass spectrometer with a heated electrospray ionization source. For positive ion the following parameters were used: ionization voltage was 3.8 kV; capillary temperature was 320 °C; sheath gas and auxiliary gas flow were 30 and 5 arbitrary units, respectively. For negative ion, the following parameters were used: ionization voltage was 3.0 kV; capillary temperature was 320 °C; sheath gas and auxiliary gas flow were 20 and 1 arbitrary units, respectively. The collision energy varied from 10 to 50 eV. The ESI-MS/MS spectra below ( Figure S-3 Figure S-3. Above are the ESI-MS/MS spectra of 14 cardiovascular drugs, amlodipine, atorvastatin calcium, felodipine, fenofibrate, furosemide, hydrochlorothiazide, lorsartan postassium, lisinopril, metoprolol succinate, pravastatin sodium, rosuvastatin calcium, simvastatin, valsartan and verapamil.
